|
|
Volumn 41, Issue 2, 2002, Pages 202-203
|
|
Oral fluoropyrimidines in the treatment of advanced colorectal cancer: Results of two consecutive phase II trials
a
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CAPECITABINE;
FLUOROPYRIMIDINE;
FOLINIC ACID;
HYDROXYUREA;
UFT;
ADULT;
BONE MARROW TOXICITY;
CANCER REGRESSION;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
COLORECTAL CANCER;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
ECHOGRAPHY;
HAND FOOT SYNDROME;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DEOXYCYTIDINE;
DIARRHEA;
DRUG COMBINATIONS;
HUMANS;
LEUCOVORIN;
NAUSEA;
SURVIVAL RATE;
TEGAFUR;
TIME FACTORS;
URACIL;
|
|
EID: 0036266314
PISSN: 0284186X
EISSN: None
Source Type: Journal
DOI: 10.1080/028418602753669625 Document Type: Letter |
|
Times cited : (2)
|
|
References (8)
|
